热卖商品
新闻详情
Hycult Biotech/IgG2b, Rat, mAb RTK4530, FITC/HI3024/50 µg
来自 :
发布时间：2024-12-23
Description: IgG2b, Rat, mAb RTK4530, FITC
The Rat IgG2b, mAb RTK4530 immunoglobulin is useful as an isotype control for several applications: Western blot, immunoprecipitation, immunohistochemistry, immunofluorescence microscopy and flow cytometry.Specifications:
| HI3024 |
| IgG2b κ |
| Isotype controls |
| 50 µg |
| FITC |
| 50 µg (0.5 mg/ml) antibody solution in PBS, containing 0.09% sodium azide. |
| Flow cytometry, Frozen sections, Immuno fluorescence, Immuno precipitation, Paraffin sections, Western blot |
| Rat |
| For mentioned applications dilutions to be used depend on detection system applied. It is recommended that users titrate the antibody for use in their system to a concentration equivalent to the test reagents. |
| Product should be stored at 4°C. Do not freeze. Under recommended storage conditions, product is stable for at least one year. The exact expiry date is indicated on the label. |
| 1. Cervantes-Barragan L, et al; Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 2007, 109:3 2. Zeiser R, et al; Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease. Blood 2007, 109:5 3. Sasaki K, et al; Stat6 signaling suppresses VLA-4 expression by CD8+ T cells and limits their ability to infiltrate tumor lesions in vivo. J. Immunol. 2008, 181:1 4. Duan J, et al; Microbial carbohydrate depolymerization by antigen-presenting cells: deamination prior to presentation by the MHCII pathway. P. Natl. Acad. Sci. USA 2008, 105:13 5. Yi H, et al; Pattern recognition scavenger receptor SRA/CD204 down-regulates Toll-like receptor 4 signaling-dependent CD8 T-cell activation. Blood 2009, 113:23 6. Schaefer J, et al; ICOS promotes IL-17 synthesis in colonic intraepithelial lymphocytes in IL-10-/- mice. J. Leukocyte Biol. 2010, 87:2 7. Zinselmeyer BH, et al; PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis. J Exp Med. 2013, 210:4 |
| For research use only. Not for use in or on humans or animals or for diagnostics. It is the responsibility of the user to comply with all local/state and federal rules in the use of this product. Hycult Biotech is not responsible for any patent infringements that might result from the use or derivation of this product. |
本文链接： http://hycult.immuno-online.com/view-1597828275.html
发布于 ： 2024-12-23
阅读（）
最新动态
1970-01-01
2013-05-29
2016-02-22
2016-04-26
2016-07-27
2016-12-06
2017-05-15
2017-09-19
2017-12-26
2018-01-08
联络我们
